200 related articles for article (PubMed ID: 37848409)
1. Neural deficits in a mouse model of PACS1 syndrome are corrected with PACS1- or HDAC6-targeting therapy.
Villar-Pazos S; Thomas L; Yang Y; Chen K; Lyles JB; Deitch BJ; Ochaba J; Ling K; Powers B; Gingras S; Kordasiewicz HB; Grubisha MJ; Huang YH; Thomas G
Nat Commun; 2023 Oct; 14(1):6547. PubMed ID: 37848409
[TBL] [Abstract][Full Text] [Related]
2. RNA-targeted therapy corrects neuronal deficits in PACS1 syndrome mice.
Villar-Pazos S; Thomas L; Yang Y; Chen K; Lyles JB; Deitch BJ; Ochaba J; Ling K; Powers B; Gingras S; Kordasiewicz HB; Grubisha MJ; Huang YH; Thomas G
Res Sq; 2023 Jan; ():. PubMed ID: 36747781
[TBL] [Abstract][Full Text] [Related]
3. iPSC-derived models of PACS1 syndrome reveal transcriptional and functional deficits in neuron activity.
Rylaarsdam L; Rakotomamonjy J; Pope E; Guemez-Gamboa A
Nat Commun; 2024 Jan; 15(1):827. PubMed ID: 38280846
[TBL] [Abstract][Full Text] [Related]
4. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
Gold WA; Lacina TA; Cantrill LC; Christodoulou J
J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
[TBL] [Abstract][Full Text] [Related]
5. Modification of cardiac disease by transgenically altered histone deacetylase 6.
Sanbe A; Inomata Y; Matsushita N; Sawa Y; Hino C; Yamazaki H; Takanohashi K; Takahashi N; Higashio R; Tsumura H; Aoyagi T; Hirose M
Biochem Biophys Res Commun; 2022 Nov; 631():48-54. PubMed ID: 36166953
[TBL] [Abstract][Full Text] [Related]
6. Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation.
Liu Y; Peng L; Seto E; Huang S; Qiu Y
J Biol Chem; 2012 Aug; 287(34):29168-74. PubMed ID: 22778253
[TBL] [Abstract][Full Text] [Related]
7. Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.
Bertels Z; Singh H; Dripps I; Siegersma K; Tipton AF; Witkowski WD; Sheets Z; Shah P; Conway C; Mangutov E; Ao M; Petukhova V; Karumudi B; Petukhov PA; Baca SM; Rasenick MM; Pradhan AA
Elife; 2021 Apr; 10():. PubMed ID: 33856345
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells.
Asthana J; Kapoor S; Mohan R; Panda D
J Biol Chem; 2013 Aug; 288(31):22516-26. PubMed ID: 23798680
[TBL] [Abstract][Full Text] [Related]
9. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
Beyer M; Kiweler N; Mahboobi S; Krämer OH
Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction.
Wattanathamsan O; Chantaravisoot N; Wongkongkathep P; Kungsukool S; Chetprayoon P; Chanvorachote P; Vinayanuwattikun C; Pongrakhananon V
J Biomed Sci; 2023 Jan; 30(1):4. PubMed ID: 36639650
[TBL] [Abstract][Full Text] [Related]
11. Cortactin deacetylation by HDAC6 and SIRT2 regulates neuronal migration and dendrite morphogenesis during cerebral cortex development.
Kim JY; Hwang HG; Lee JY; Kim M; Kim JY
Mol Brain; 2020 Jul; 13(1):105. PubMed ID: 32711564
[TBL] [Abstract][Full Text] [Related]
12. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation.
Haggarty SJ; Koeller KM; Wong JC; Grozinger CM; Schreiber SL
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4389-94. PubMed ID: 12677000
[TBL] [Abstract][Full Text] [Related]
13. Genetic characterization of Schuurs-Hoeijmakers syndrome in a moroccan individual with heterozygote PACS1 mutation.
Abbassi M; Bourmtane A; Sayel H; El Mouhi H; Jalte M; Elasri YA; Askander O; El Fahime E; Bouguenouch L
Mol Biol Rep; 2023 Nov; 50(11):9121-9128. PubMed ID: 37747683
[TBL] [Abstract][Full Text] [Related]
14. Loss of deacetylation activity of Hdac6 affects emotional behavior in mice.
Fukada M; Hanai A; Nakayama A; Suzuki T; Miyata N; Rodriguiz RM; Wetsel WC; Yao TP; Kawaguchi Y
PLoS One; 2012; 7(2):e30924. PubMed ID: 22328923
[TBL] [Abstract][Full Text] [Related]
15. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
Noack M; Leyk J; Richter-Landsberg C
Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
[TBL] [Abstract][Full Text] [Related]
16. Hdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6/2 mouse model of Huntington's disease.
Bobrowska A; Paganetti P; Matthias P; Bates GP
PLoS One; 2011; 6(6):e20696. PubMed ID: 21677773
[TBL] [Abstract][Full Text] [Related]
17. Rutin increases alpha-tubulin acetylation via histone deacetylase 6 inhibition.
Çetin Ö; Sari S; Erdem-Yurter H; Bora G
Drug Dev Res; 2022 Jun; 83(4):993-1002. PubMed ID: 35266183
[TBL] [Abstract][Full Text] [Related]
18. HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving α-tubulin acetylation.
Song R; Yang Y; Lei H; Wang G; Huang Y; Xue W; Wang Y; Yao L; Zhu Y
J Mol Cell Cardiol; 2018 Nov; 124():58-69. PubMed ID: 30315806
[TBL] [Abstract][Full Text] [Related]
19. HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation.
Gal J; Chen J; Barnett KR; Yang L; Brumley E; Zhu H
J Biol Chem; 2013 May; 288(21):15035-45. PubMed ID: 23580651
[TBL] [Abstract][Full Text] [Related]
20. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
Yu J; Ma Z; Shetty S; Ma M; Fu J
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
